» Articles » PMID: 35140209

Selenophosphate Synthetase 1 Deficiency Exacerbates Osteoarthritis by Dysregulating Redox Homeostasis

Overview
Journal Nat Commun
Specialty Biology
Date 2022 Feb 10
PMID 35140209
Authors
Affiliations
Soon will be listed here.
Abstract

Aging and mechanical overload are prominent risk factors for osteoarthritis (OA), which lead to an imbalance in redox homeostasis. The resulting state of oxidative stress drives the pathological transition of chondrocytes during OA development. However, the specific molecular pathways involved in disrupting chondrocyte redox homeostasis remain unclear. Here, we show that selenophosphate synthetase 1 (SEPHS1) expression is downregulated in human and mouse OA cartilage. SEPHS1 downregulation impairs the cellular capacity to synthesize a class of selenoproteins with oxidoreductase functions in chondrocytes, thereby elevating the level of reactive oxygen species (ROS) and facilitating chondrocyte senescence. Cartilage-specific Sephs1 knockout in adult mice causes aging-associated OA, and augments post-traumatic OA, which is rescued by supplementation of N-acetylcysteine (NAC). Selenium-deficient feeding and Sephs1 knockout have synergistic effects in exacerbating OA pathogenesis in mice. Therefore, we propose that SEPHS1 is an essential regulator of selenium metabolism and redox homeostasis, and its dysregulation governs the progression of OA.

Citing Articles

Unveiling the Role of Selenium in Child Development: Impacts on Growth, Neurodevelopment and Immunity.

Batyrova G, Taskozhina G, Umarova G, Umarov Y, Morenko M, Iriskulov B J Clin Med. 2025; 14(4).

PMID: 40004804 PMC: 11856779. DOI: 10.3390/jcm14041274.


Comparative effects of selenium-enriched lactobacilli and selenium-enriched yeast on performance, egg selenium enrichment, antioxidant capacity, and ileal microbiota in laying hens.

Zhou J, Obianwuna U, Zhang L, Liu Y, Zhang H, Qiu K J Anim Sci Biotechnol. 2025; 16(1):27.

PMID: 39966907 PMC: 11837603. DOI: 10.1186/s40104-025-01160-6.


Regulation of senescence-associated secretory phenotypes in osteoarthritis by cytosolic UDP-GlcNAc retention and O-GlcNAcylation.

Kang D, Lee J, Yook G, Jeong S, Shin J, Kim M Nat Commun. 2025; 16(1):1094.

PMID: 39904978 PMC: 11794700. DOI: 10.1038/s41467-024-55085-1.


A ROS-responsive hydrogel encapsulated with matrix metalloproteinase-13 siRNA nanocarriers to attenuate osteoarthritis progression.

Wang Q, Feng K, Wan G, Liao W, Jin J, Wang P J Nanobiotechnology. 2025; 23(1):18.

PMID: 39815302 PMC: 11737235. DOI: 10.1186/s12951-024-03046-7.


Novel insights into the role of metabolic disorder in osteoarthritis.

Yu C, Zhao S, Yue S, Chen X, Dong Y Front Endocrinol (Lausanne). 2025; 15():1488481.

PMID: 39744183 PMC: 11688211. DOI: 10.3389/fendo.2024.1488481.


References
1.
Loeser R, Goldring S, Scanzello C, Goldring M . Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 2012; 64(6):1697-707. PMC: 3366018. DOI: 10.1002/art.34453. View

2.
Brandt K, Radin E, Dieppe P, van de Putte L . Yet more evidence that osteoarthritis is not a cartilage disease. Ann Rheum Dis. 2006; 65(10):1261-4. PMC: 1798332. DOI: 10.1136/ard.2006.058347. View

3.
Little C, Hunter D . Post-traumatic osteoarthritis: from mouse models to clinical trials. Nat Rev Rheumatol. 2013; 9(8):485-97. DOI: 10.1038/nrrheum.2013.72. View

4.
Muir H . The chondrocyte, architect of cartilage. Biomechanics, structure, function and molecular biology of cartilage matrix macromolecules. Bioessays. 1995; 17(12):1039-48. DOI: 10.1002/bies.950171208. View

5.
Mobasheri A, Rayman M, Gualillo O, Sellam J, van der Kraan P, Fearon U . The role of metabolism in the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2017; 13(5):302-311. DOI: 10.1038/nrrheum.2017.50. View